May Highlights: TrialKey’s Impactful Events and Media Coverage
May has been a remarkable month for TrialKey, filled with high-profile events and engaging media coverage. These opportunities have significantly boosted our visibility and strengthened our connections with pharmaceutical companies, clinical research organisations, and investors. Here’s a recap of our exciting journey this past month.
Digital Health Festival 2024
On May 7-8, we were honoured to participate in the Digital Health Festival in Melbourne, the region’s premier health transformation event. Our Executive Chairman, Saurabh Jain, joined a panel to discuss “How AI is Currently Supporting Clinical Decision-Making.” This platform allowed us to demonstrate the capabilities of TrialKey.ai and our innovative clinical trial simulator. Engaging with medical researchers, investors, and clinical trial sites, we showcased how our technology can streamline operations and enhance efficiency. A notable highlight was our interaction with a clinical trial site aiming to reduce over-resourcing, where we demonstrated the tangible impact of TrialKey.ai.
Pharma and Device Forum 2024
During the Pharma and Device Forum, Saurabh Jain’s keynote on ‘The Role of AI in Clinical Trial Design’ resonated with pharmaceutical representatives, highlighting how AI can transform trial outcomes. His presentation demonstrated how TrialKey can analyse extensive datasets to provide researchers with insights into past successes and current trends, illustrating our potential in improving clinical trial success rates.
Global Clinical Trials Connect
At the Global Clinical Trials Connect in London, Saurabh Jain and CTO Damon Rasheed discussed “The Trial Before the Trial: How TrialKey.ai is Shaping the Future of Medical Research.” This event brought together a global community of CROs and pharmaceutical professionals. We showcased how TrialKey’s advanced simulation and analysis tools are revolutionising clinical trial designs, making the process more efficient and effective.
Private Investor Presentation
We hosted an exclusive, invite-only private investor presentation. CTO Damon Rasheed and Executive Chairman Saurabh Jain unveiled the clinical trial success probabilities using TrialKey for five pharmaceutical companies listed on the ASX. This session provided invaluable insights, empowering investors in the biopharma space to make strategic decisions based on success probabilities and phase results timing. Our software offers a unique perspective on the biopharma landscape, helping investors gauge the potential success of ongoing trials and make informed investment choices.
Media Coverage: Amplifying Our Reach
Our media presence has also been remarkable this month, further solidifying our influence in the industry.
Talking Healthtech Podcast
Saurabh Jain and Damon Rasheed joined Nathan Moore on the Talking Healthtech podcast, reaching over 30,000 listeners. They discussed how predictive analysis systems are revolutionising clinical trial design and outcomes, highlighting how AI and big data can streamline processes and potentially save billions in healthcare spending. Listen now
Herald Sun Press Coverage
An online feature in the Herald Sun emphasised TrialKey’s role in optimising clinical trials through AI. The article highlighted our capabilities in improving success rates and the strategic advantages for pharmaceutical companies and research organisations. Read more
Stockhead Press Coverage
Dubbed the “ChatGPT” for clinical trials, Stockhead’s article elaborated on our simulator’s capabilities and the comprehensive insights provided through our custom reports. This coverage reinforced our leadership position in the field. Read more
Eye on AI Podcast
Saurabh Jain and Damon Rasheed discussed how TrialKey’s AI model predicts the success of clinical trials with over 90% accuracy and optimises trial designs for any phase. Listen now
CEO & Founder Magic Podcast
In an insightful conversation with Sheila Kloefkorn, Saurabh Jain shared his experiences as a senior executive and visionary leader, offering valuable advice for startup growth. Listen now
Inspired by Success Podcast
CTO Damon Rasheed discussed the passion and drive behind TrialKey and how AI is set to save lives by enhancing clinical trials. Listen now
Conclusion
Participating in these events and media engagements has been invaluable for TrialKey. They have not only increased our visibility but also connected us with key decision-makers, enhancing our sales pipeline and expanding our influence in the clinical trials community. For our investors, these developments highlight the growing interest and trust in TrialKey’s innovative solutions, reinforcing our commitment to driving transformative change in the healthcare sector.
